All cancers begin with one malfunctioning cell, irrespective of whether they form in the lungs, liver, colon, pancreas, etc. Every single day, trillions of new cells form inside the human body. This involves an elaborate sequence involving growth, division, and death of individual cells. When this delicate balance fails to operate effectively, a malignant cancer forms.
In this case, the cell grows and divides at its own will. It avoids any form of regulatory control and resists programmed cell death (apoptosis).
On this blog, we examine precisely how a single cancer cell evolves into a full-blown, spreading cancer mass. It's an in-depth analysis of the biology behind the cancer phenomenon that makes it particularly hard to combat once started.
The Normal Cell Cycle: What's Supposed to Happen
Before explaining what happens when there's something wrong, let's start with a brief overview of what happens under normal conditions. Cells go through an extremely regulated cellular process known as the cell cycle, during which they grow, replicate their DNA, and split into daughter cells. Throughout various stages within this cycle, the cell stops at checkpoints in order to conduct its internal inspection using specific types of proteins.
Depending on whether the inspection reveals problems or not, two situations may arise:
-
In case any abnormalities have been detected, the cell tries to repair its DNA using specific DNA repair pathways.
-
When DNA cannot be restored, apoptosis kicks in as a mechanism for removing the dysfunctional cells via programmed death.
This system operates efficiently in almost all circumstances. Nearly all DNA damage caused either by cellular activity, UV rays, or other chemicals gets fixed or eliminated in the majority of cases. Abnormalities only occur when the entire quality control system fails. That leads to cancer developing.
Step One: DNA Mutation
The origins of cancer involve damage to the cellular genetic code, specifically DNA. These changes to the genetic code are known as mutations and may occur due to any of the following factors:
-
Mistakes made in cellular division and DNA replication. Cells sometimes make mistakes when duplicating their DNA before splitting into two daughter cells.
-
Exposure to damaging environmental conditions, such as carcinogenic compounds found in cigarette smoke, ultraviolet light, or toxic industrial substances.
-
Genetic predisposition from one's parents. Some people carry harmful mutations from conception, affecting their risk of developing cancer throughout life.
-
Infection with viruses that can disrupt cellular genetics, examples being HPV infections and hepatitis B/C infections.
A lone mutation rarely results in the onset of cancer. The immune system and other physiological safety measures can identify and correct or destroy abnormal cells effectively. Multiple mutations within one cell usually precede cancers because they overwhelm the body's safeguards against these genetic defects. The increased likelihood of getting cancer as we grow older is partly attributed to the accumulation of various genetic mutations throughout many years.
Step Two: Losing the Brakes and the Accelerator
It is crucial to know which kinds of mutations cause cancer, as some are more harmful than others. Here are two categories of genetic changes that promote carcinogenesis by interfering with normal cell proliferation processes.
Oncogenes: The Stuck Accelerator
Normal proto-oncogenes regulate cell proliferation. These genes work similarly to the gas pedal of a car—when mutated into oncogenes, however, they cause cells to proliferate uncontrollably. Mutations in proto-oncogenes lead to permanent activation of growth-promoting proteins irrespective of the need for growth. For instance, a common KRAS mutation permanently activates a signaling protein involved in cell proliferation.
Tumor Suppressor Genes: The Broken Brakes
On the contrary, tumor suppressors usually act as breaks in the process of cell proliferation. They inhibit the cell cycle, fix any mistakes during replication, and initiate apoptosis when necessary. The gene responsible for those functions is known as p53, and is commonly referred to as the "guardian of the genome." This gene recognizes damaged DNA strands, stops the cell cycle to fix any problems, or triggers apoptosis when it detects excessive damage.
DNA Repair Genes: The Broken Quality Inspector
Another type of gene called DNA repair genes helps correct mistakes during the cell cycle process. If this group of genes is defective, mutations accumulate more rapidly throughout the genome. The chances are high that other essential genes controlling cell proliferation could become mutated later.
Cancer usually involves the disruption of multiple categories mentioned above. An oncogene activation might suffice only when there are tumor suppression genes and proper DNA repair processes operating correctly within a cell. This is one reason behind cancer being referred to as having to suffer "multiple hits" before it becomes established in biology.
Step Three: Uncontrolled Proliferation
If the cell develops a sufficient number of genetic changes, the cell will continue dividing uncontrollably without stopping. In turn, there will be an increasing number of abnormal cells, all originating from that one initial cell, called clonal expansion.
These abnormal cells can then create a tumor. These tumors may be considered:
-
Benign – abnormal growth that remains localized and does not spread into neighboring tissues
-
Malignant – cancerous growths that can grow into neighboring tissues, then migrate to other parts of the body.
However, not all abnormalities lead to malignant tumors. Many abnormal and pre-malignant lesions, including colon polyps, may remain static forever or can even be surgically eliminated at this phase.
Step Four: Evading the Immune System
As the name implies, the immune surveillance theory describes how your body’s immune system recognizes and eliminates cancerous tumors. However, those cancer cells which have managed to form a visible tumor mass must have evaded the immune surveillance somehow. How do they do this?
-
Firstly, they manage to mask their presence from immune recognition.
-
Secondly, cancer cells secrete factors that inhibit local immunity within the tumor area.
-
Thirdly, they attract non-cancerous cells to form an additional layer of protection around themselves.
That's why immunotherapy drugs are becoming increasingly popular these days—they help restore the ability of the immune system to detect and kill cancer cells. It sounds promising, but please keep in mind that while your genes and immune responses may vary greatly from one person to another.
Step Five: Building a Blood Supply
A mass cannot continue growing past several millimeters without being fed nutrients and oxygen via blood vessels. For this reason, tumors initiate a biological response called angiogenesis, whereby new blood vessels grow directly into the tumor mass. The importance of angiogenesis in tumor growth is illustrated by the fact that some anti-cancer medications are specifically designed to block angiogenesis in tumors.
Step Six: Invasion and Metastasis
The last stage of cancer, where the disease becomes truly deadly, involves metastasis—the spread of the cancer cells away from the primary site of origin via the blood or lymphatic circulation and establishment as secondary tumors in different areas within the patient's body.
This is usually achieved when cancer cells:
-
Separate themselves from their initial site and invade neighboring tissues,
-
Travel through the circulatory systems (lymphatics or blood vessels),
-
Survive during this trip (since the majority does not survive the transit phase),
-
Exit out from the blood circulation and enter another tissue area, forming tumors again.
Cancer metastasis is precisely what makes cancer a systematic illness rather than a local one, making it untreatable. This is why cancer staging considers metastasis critically important when determining how malignant the tumor is, which explains why detecting cancer before metastasis occurs plays such a vital role.
Why This Process Takes Time
If you are asking yourself, “Is there any way cancer could start quickly?” The answer is no, not really. It takes the accumulation of several different gene mutations and subsequent processes of evading the immune response, developing a blood supply, and invading surrounding tissue.
Most estimates place cancer initiation at taking place many years—if not decades—before diagnosis occurs. By that point, the cancer has gone through all those stages without the patient realizing anything is wrong yet.
The reason why the risk increases so sharply with time and age becomes clear now. This is precisely why cancer screenings exist; the ability to detect abnormal cell growth or tumors at an early stage while it is still possible to eliminate it before it avoids the immune response, develops its blood supply, or invades nearby tissue is critical.
Why Understanding Matters
Understanding cancer development mechanisms is important because it clarifies why our treatment approaches are effective:
-
Chemotherapy works against fast-dividing cancerous cells because it utilizes the proliferation phase in its mechanism of action.
-
Targeted therapies target certain cancer-causing proteins known as oncogenes.
-
Immuno-oncology treatments target cancer's evasion strategies when dealing with the patient's immune response.
-
Anti-angiogenesis drugs prevent tumor growth by cutting off the nutrient supply from the blood vessels.
-
Cancer screenings are done because it takes decades for this process to complete.
Final Thoughts
Cancer does not happen all at once; rather, it is an entire series of biological events spanning many years in which a typical cell progressively loses its ability to regulate itself genetically, avoids the immune system, forms its own circulatory system, and ultimately acquires the potential for metastasis.
Each individual phase is simultaneously an inherent weak point in the progression of cancer that can be taken advantage of for treatment purposes and proof that early intervention is essential. Recognizing the nature of the disease progression makes sense of the medical approaches associated with it, such as screenings and immunotherapies